About

Thomas Sellig has served as an Achieve Life Sciences director since 2023, chairing the Nominating and Governance Committee and serving on the Audit Committee. He has been Chief Executive Officer of Adare Pharmaceuticals, Inc., a technology-driven contract development and manufacturing organization, since January 2022, and was previously Chief Executive Officer of LabConnect, Inc. (2019-2021) and Chief Commercial Officer at PSKW, LLC (ConnectiveRx). Earlier he was Senior Vice President of Global Sales at Patheon N.V. and, following its 2017 acquisition, Thermo Fisher Scientific, and held sales and alliance-management leadership roles at Covance. Mr. Sellig received his B.A. in Economics from Vanderbilt University and an M.B.A. from New York University.

Roles

Achieve Life Sciences, Inc.
Director (Chair, Nominating and Governance Committee) · Current role
2023–present
Adare Pharmaceuticals, Inc.
Chief Executive Officer
2022 - present
LabConnect, Inc.
Chief Executive Officer
2019 - 2021
PSKW, LLC (ConnectiveRx)
Chief Commercial Officer
2018 - 2019
Patheon N.V. / Thermo Fisher Scientific
SVP of Global Sales
2014 - 2018
Covance
Global VP of Sales / VP Strategic Partnering
2007 - 2014

Director Compensation

FY 2025
Fees earned or paid in cash
$57,500
ComponentNon-employee director cash retainers and fees earned in FY2025
Option awards
$81,930
ComponentAnnual director stock-option grant, ASC 718 grant-date fair value
Total
$139,430

Also at Achieve Life Sciences, Inc.

Related

See how VectorShift works for your firm

Request Demo